Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

24
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
24
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

214
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
214
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

543
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
543
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

58
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
58

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Direct Consideration of Process History During Intensified Design of Experiments Planning Eases Interpretation of Mammalian Cell Culture Dynamics.

Bioengineering (Basel, Switzerland)·2025
Same author

Lifecycle DoE-The Companion for a Holistic Development Process.

Bioengineering (Basel, Switzerland)·2024
Same author

High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology.

International journal of molecular sciences·2024
Same author

Bounded rational decision-making models suggest capacity-limited concurrent motor planning in human posterior parietal and frontal cortex.

PLoS computational biology·2022

相关实验视频

Updated: May 25, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K

在生物制药过程中用于差异估计的贝叶斯分层建模.

Sonja Schach1, Tobias Eilert2, Beate Presser1

  • 1CMC Statistics Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach an der Riß, Germany.

Bioengineering (Basel, Switzerland)
|February 26, 2025
PubMed
概括

一个新的贝叶斯模型使用元分析增强生物制药过程方差估计. 这种方法在有限的数据中提高了关键质量属性的可靠性,有助于更快的药物开发和确保患者安全.

关键词:
贝叶斯式借贷方式生物制药过程的可变性异种类型的过程建模.位置尺度模型模型进行元分析.随机效应差异的随机效应差异.

更多相关视频

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.3K
Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method
09:12

Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method

Published on: May 19, 2023

568

相关实验视频

Last Updated: May 25, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.3K
Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method
09:12

Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method

Published on: May 19, 2023

568

科学领域:

  • 生物制药制造业 生物制药制造业
  • 统计建模 统计建模
  • 通过设计的质量.

背景情况:

  • 准确的过程方差估计在生物制药制造中至关重要.
  • 有限的数据可用性对可靠的差异确定构成重大挑战.
  • 现有的方法与数据稀缺性作斗争,影响过程开发和质量评估.

研究的目的:

  • 介绍一个贝叶斯层次模型,用于对过程方差的元分析.
  • 在数据稀缺的场景中,改进对流程差异和关键质量属性 (CQA) 的估计.
  • 加强过程模型的评估,支持生物制药开发的质量.

主要方法:

  • 开发一个贝叶斯的层次模型用于元分析.
  • 整合来自多个产品的数据,以增强差异估计.
  • 该模型应用于上游和下游的制造工艺.

主要成果:

  • 该模型提供了更可靠的过程方差估计,特别是在有限的数据.
  • 通过模拟研究证明了有效性.
  • 对未来的CMC (化学,制造和控制) 药物开发利用历史数据的潜力.

结论:

  • 拟议的统计模型有效地解决了生物制药过程方差分析中的数据稀缺问题.
  • 它有助于更强大的流程评估和质量保证.
  • 该方法可以加快新疗法进入市场的速度,同时保持患者安全和产品质量.